SCHEDULE: Long Path Funds Adjust Mesa Labs Stake

Long Path Smaller Companies Fund, LP and affiliated entities report a beneficial ownership of 7.3% in Mesa Laboratories, Inc. as of March 31, 2026.

Summary

• This filing is an amendment to a Schedule 13G, indicating a change in beneficial ownership of Mesa Laboratories, Inc. common stock.
• The reporting persons, including Long Path Smaller Companies Fund, LP, Long Path Fund GP, LLC, Long Path Partners, LP, Long Path Holdings LLC, William Thomas Brennan, and Brian Paul Nelson, collectively hold 405,583 shares.
• This holding represents 7.3% of the class of securities outstanding.
• The shares are directly held by Long Path Smaller Companies Fund, LP.
• The reporting persons have agreed to file jointly.
• The filing certifies that the securities were not acquired or held for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership and does not contain operational or financial performance information.

Positives

• The reporting persons collectively hold a significant stake of 7.3% in Mesa Laboratories, Inc., indicating substantial investor confidence.
• The joint filing agreement suggests a coordinated investment strategy among the reporting entities.

Negatives

• No specific financial performance data or operational updates are provided in this filing, as it is purely an ownership disclosure.

Risks

• The filing does not explicitly mention any risks. However, any significant change in ownership by a large shareholder could potentially influence market perception or future corporate actions, which might be viewed as an indirect risk by some investors.

Future Outlook

This filing is an amendment to a Schedule 13G and does not contain forward-looking statements or guidance regarding the company's future performance.

Management Comments

• Each Reporting Person disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.
• The securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and investment funds to disclose significant ownership stakes. This filing indicates Long Path Funds' continued or adjusted interest in Mesa Laboratories, Inc., a company operating in the laboratory equipment and services sector.

Stakeholder Impact

• Shareholders: The increased or adjusted stake by Long Path Funds may signal continued investor interest, potentially influencing market sentiment. Other shareholders will monitor the actions of this significant holder.
• Management: The reporting persons certify that their holdings are not intended to influence control, which could be reassuring to current management.
• Creditors: No direct impact is indicated.

Next Steps

• No specific next steps are outlined in this filing beyond the ongoing reporting requirements for beneficial ownership.

Key Dates

Keywords

Mesa Laboratories, Schedule 13G, SEC Filing, Beneficial Ownership, Long Path Funds, Investment, Securities, Amendment